 |
Distribution Agreement for Menoflavon® in Tunisia and Algeria
Posted on: Monday, November 22, 2010
BioProgress Technology Limited is pleased to announce it has signed a sales and distribution agreement with Vitalpharma Laboratoires for Tunisia and Pharmalys Algerie for Algeria for the Menoflavon® range of products.
The updated Product Availability Matrix can be viewed at Product Availabilty
|
 |
Company Announcement
The directors of BioProgress Technology Ltd (BTL) are pleased to announce that the entire share capital of the Company has been acquired by XGEL Limited. XGEL Limited shareholders can access and register for the XGEL Forum via the XGEL button on the home page.
|
|
|
Distribution Agreement for Menoflavon® in United Kingdom and Republic of Ireland…
BioProgress Technology Limited is pleased to announce it has signed a sales and distribution agreement with Vitabiotics Ltd for Menoflavon®, red clover and green tea, to be marketed within the Menopace® product range, the UK number one selling supplement for the menopause. The one-a-day capsule includes the patented 40mg isoflavones from Red Clover plus green tea extract.
The product will be avamore
|